Food and Drug Administration

RFK Jr. HHS leadership, vaccine policy & legal challenges

70 clusters · 315 sources · last updated about 12 hours ago

Latest: Robert F. Kennedy Jr. advances food and vaccine safety initiatives

Since his April 2026 appointment, HHS Secretary Robert F. Kennedy Jr. has reshaped U.S. health governance, installing acting heads at the CDC, NIH, FDA and the Surgeon‑General’s office. He issued rules on ultra‑processed

GLP-1 drugs: clinical trends, safety, and market shifts

302 clusters · 1130 sources · last updated about 12 hours ago

Latest: Weight loss medications drive consumer shifts and counterfeit drug risks

Since mid-2026, the expansion of GLP-1 agents for obesity has been accompanied by intensified safety monitoring and evolving clinical data. Research suggests secondary benefits, including a 21% lower risk of fragility fr

FDA rare disease drug development reform

3 clusters · 10 sources · last updated 1 day ago

Latest: FDA launches initiative to standardize rare disease drug reviews

The U.S. Food and Drug Administration (FDA) has launched the ‘Rare Disease Framework Initiative’ to redesign the development and review process for drugs and biologics targeting rare conditions. The initiative seeks to m

Maharashtra drought impact on sugarcane production

2 clusters · 4 sources · last updated 1 day ago

Latest: Maharashtra reports major drought losses and administrative changes

The sugarcane crushing season in Maharashtra has commenced, but industry experts warn of a potential 20% to 25% decline in sugar production compared to the previous season. Although the total cultivation area has increas

FDA approves Rasonque for pancreatic cancer; EMA recommends

43 clusters · 318 sources · last updated 2 days ago

Latest: EMA recommends approval of Daraxonrasib for metastatic pancreatic cancer

On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R

US beef import tariffs and industry restructuring

26 clusters · 381 sources · last updated 2 days ago

Latest: Nebraska ranchers question Trump support amid cattle market crisis

The suspension of out-of-quota tariffs on up to 300,000 metric tons of imported lean beef trimmings, which commenced on September 1, 2026, is being implemented in three 100,000-ton installments across September, October,

Alzheimer's research: Detection, trials, and efficacy debate

21 clusters · 80 sources · last updated 2 days ago

Latest: Alzheimer's research links amyloid removal to reduced tau protein buildup

Research into Alzheimer’s disease continues to evolve, focusing on early detection, molecular mapping, and the physiological breadth of the condition. While previous efforts emphasized biomarkers and AI-driven diagnostic

Maharashtra FDA Commissioner enforcement controversy

8 clusters · 27 sources · last updated 2 days ago

Latest: Maharashtra FDA intensifies food safety enforcement across businesses

Maharashtra Food and Drug Administration (FDA) Commissioner Tukaram Mundhe has faced internal and external scrutiny following his aggressive enforcement of food safety standards. In late July 2026, thirty-nine employees

Respiratory virus vaccination guidance and developments

15 clusters · 59 sources · last updated 3 days ago

Latest: Alabama health organizations urge seasonal vaccinations

The respiratory virus vaccination season has officially commenced in North America, with health authorities emphasizing protection against influenza, COVID-19, and respiratory syncytial virus (RSV). In the United States,

MHRA regulatory strategy and international cooperation

2 clusters · 6 sources · last updated 4 days ago

Latest: MHRA unveils 2030 strategy focused on AI and patient safety

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has expanded its focus on international cooperation and future technological integration. In September 2026, the MHRA strengthened its regulatory partn

AI healthcare integration expands amid privacy and cost's

23 clusters · 105 sources · last updated 4 days ago

Latest: AI medical advice poses hidden health risks due to lack of transparency

Since the July 2026 summit, AI deployment in healthcare has accelerated toward a collaborative model, though integration is increasingly complicated by privacy and economic tensions. Clinicians are increasingly adopting

US medical equipment accessibility and Medicare regulation

2 clusters · 5 sources · last updated 4 days ago

Latest: Medical organizations comment on CMS RAPID coverage pathway

The United States has introduced new federal mandates to improve medical equipment accessibility for individuals with disabilities. Under the Rehabilitation Act and the Americans with Disabilities Act, the Department of

US psychedelic therapy regulatory and research developments

5 clusters · 12 sources · last updated 4 days ago

Latest: FDA holds hearing on regulatory future of psychedelic therapies

The U.S. Food and Drug Administration (FDA) is working to develop a new framework to accelerate patient access to psychedelic medicines, such as psilocybin and DMT, to address the national mental health crisis. During a

US animal welfare and testing policy updates

3 clusters · 11 sources · last updated 4 days ago

Latest: Trump administration proposes new animal welfare standards

The U.S. Department of Agriculture (USDA) and the Department of Health and Human Services (HHS) have launched initiatives to enhance oversight and welfare for companion animals and reduce reliance on animal testing. In

US legislative efforts regarding mifepristone

2 clusters · 4 sources · last updated 5 days ago

Latest: U.S. lawmakers demand FDA updates on mifepristone safety study

In late September 2026, Senator Josh Hawley introduced the ‘Safeguarding Women from Chemical Abortion Act,’ calling for a congressional ban on the abortion medication mifepristone. Hawley argued the drug is unsafe for bo

Global peptide research and regulatory developments

3 clusters · 14 sources · last updated 5 days ago

Latest: Peptides gain popularity for human performance and pet care

Peptides are experiencing increased interest across medical, wellness, and skincare sectors, driven by scientific research into longevity and the popularity of GLP-1 medications. In the United States, an FDA advisory com

US respiratory illness vaccination and prevention guidance

5 clusters · 11 sources · last updated 5 days ago

Latest: Public health experts warn of early flu season and vaccination barriers

Health experts and specialists are providing guidance for the upcoming respiratory illness season, focusing on influenza and COVID-19. Initial guidance emphasized the timing of vaccinations. While the FDA had determined

Health risks of vitamin deficiency and supplementation

16 clusters · 35 sources · last updated 6 days ago

Latest: Health risks of excessive vitamin and supplement use

Medical experts continue to warn against the unregulated use of dietary supplements, emphasizing that ‘natural’ products can pose significant health risks. Recent scrutiny has focused on Vitamin D quality and dosage. A s

MPSC Drug Inspector recruitment paper leak scandal

9 clusters · 34 sources · last updated 6 days ago

Latest: MPSC aspirants end protest as Maharashtra forms inquiry panel into paper leaks

The Maharashtra Public Service Commission (MPSC) recruitment process for 154 Drug Inspector positions was cancelled following a major paper leak scandal involving the March 22 screening exam. Initial investigations by th

Eli Lilly retatrutide development and black market issues

11 clusters · 32 sources · last updated 7 days ago

Latest: Incretin agonists show potential in obesity treatment amid safety concerns

In early August 2026, Eli Lilly announced that its experimental obesity treatment retatrutide achieved substantial weight-loss outcomes in two phase-3 trials. Participants lost up to 22.6% of body weight over 80 weeks in

Advancements in Alzheimer's detection, AI, and drug access

18 clusters · 83 sources · last updated 8 days ago

Latest: Dementia diagnosis and new drugs improve patient outlook

Research into Alzheimer's biomarkers continues to evolve, with recent findings refining the utility of blood-based testing. While plasma p-tau217 remains a key indicator, studies suggest its predictive power in symptom-f

FDA concludes Cyclospora investigation into Taylor Farms

59 clusters · 1176 sources · last updated 9 days ago

Latest: FDA implements 10-point plan following Cyclospora lettuce outbreak

The FDA has concluded its investigation into the record-breaking Cyclospora outbreak linked to Taylor Farms shredded iceberg lettuce, confirming a link to the company’s facilities in Mexico. Inspectors identified the par

FDA panel recommends benefits of Grail Galleri test

3 clusters · 30 sources · last updated 9 days ago

Latest: Grail's Galleri cancer blood test nears FDA approval

GRAIL, Inc. is moving closer to potential FDA approval for its Galleri multi-cancer early detection blood test following a recommendation from the Molecular and Clinical Genetics Devices Committee. On September 23, 2026,

Recalls of supplements with undeclared ingredients

3 clusters · 9 sources · last updated 10 days ago

Latest: AEMPS recalls El Toro due to undeclared sildenafil

Health authorities in the United States and Spain have issued recalls for various natural supplements after discovering they contained undeclared pharmaceutical ingredients. In the United States, A&P Creations LLC recal

Sarcopenia Prevention and Muscle-Preserving Medical Trends

18 clusters · 58 sources · last updated 10 days ago

Latest: Strength training and protein intake recommended to combat muscle loss in aging adults

By early October 2026, medical focus has intensified on the management of sarcopenia, particularly regarding the nutritional complexities faced by patients with chronic kidney disease (CKD). While the general elderly pop

U.S. legal challenges to mifepristone access

3 clusters · 24 sources · last updated 10 days ago

Latest: Mifepristone access legal battle reaches U.S. 5th Circuit Court

Legal challenges regarding the nationwide availability of the abortion medication mifepristone have progressed through the U.S. federal court system. In late August, U.S. Chief District Judge Reed O’Connor paused a fede

Food safety and produce cleaning guidance

3 clusters · 6 sources · last updated 12 days ago

Latest: Food safety guidelines for washing fruits and vegetables

Food safety experts are providing guidance on the most effective ways to clean produce to remove pesticides and debris. Authorities emphasize that while soaking can be a supplementary step, it is essential to rinse fruit

Dementia care medication and management challenges

2 clusters · 5 sources · last updated 12 days ago

Latest: Dementia care challenges involve medication management and family strain

Discussions surrounding dementia care have centered on the controversial use of antipsychotic medications to manage patient agitation. In one instance in Michigan, a dispute between a family and a senior living facility

Iran pharmaceutical crisis: supply chain and rising costs

15 clusters · 21 sources · last updated 12 days ago

Latest: Iran healthcare crisis worsens as medical costs soar

Iran continues to face severe financial and liquidity pressures affecting its pharmaceutical sector. While total essential drug shortages decreased from 341 items in 2022 to approximately 65 in recent months, recent repo

US frozen berry E. coli recalls

5 clusters · 28 sources · last updated 12 days ago

Latest: Walmart and Trader Joe's recall frozen berries over E. coli risk

A food safety concern involving frozen berries has expanded across multiple retailers due to potential E. coli O145:H28 contamination. Initially, the U.S. Food and Drug Administration (FDA) upgraded a recall for Publix